Effectiveness of Nirsevimab on Primary Care Visits for RSV-Associated Acute Otitis Media in Infants

Key Points

• The aim is to evaluate the effectiveness of nirsevimab in reducing primary care visits for RSV-associated acute otitis media in infants.
• Evaluated the protective effect of nirsevimab on respiratory tract infections.
• Focused on infants with symptoms of acute otitis media.
• Compared primary care visit rates before and after nirsevimab treatment.
• Demonstrated a reduction in primary care visits for acute otitis media among treated infants.
• Indicated a protective effect against complications from respiratory infections.